• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“代谢记忆”理论与高血糖的早期治疗对预防糖尿病并发症的作用

The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.

作者信息

Testa Roberto, Bonfigli Anna Rita, Prattichizzo Francesco, La Sala Lucia, De Nigris Valeria, Ceriello Antonio

机构信息

Experimental Models in Clinical Pathology, INRCA-IRCCS National Institute, Ancona I-60127, Italy.

Scientific Direction, INRCA-IRCCS National Institute, Ancona I-60127, Italy.

出版信息

Nutrients. 2017 Apr 28;9(5):437. doi: 10.3390/nu9050437.

DOI:10.3390/nu9050437
PMID:28452927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5452167/
Abstract

Several epidemiological and prospective studies suggest that an early intensive control of hyperglycaemia is able to decrease the risk of diabetic micro- and macro-vascular complications. A growing body of experimental evidence supports the concept that the risk for diabetes complications may be linked to oxidative stress, non-enzymatic glycation of proteins, epigenetic changes, and chronic inflammation, laying the foundation for the "metabolic memory" theory. From a clinical point of view, this theory supports the need for a very early aggressive treatment, with the goal of normalizing metabolic control as soon as possible. It may also prove beneficial to introduce therapeutic agents that are able to reduce reactive species and glycation, in addition to presenting better control of glucose levels in patients with diabetes, in order to minimize long-term diabetes complications. In this review, we evaluate the effect of glucose intake and metabolism in the light of this theory.

摘要

多项流行病学和前瞻性研究表明,早期强化控制高血糖能够降低糖尿病微血管和大血管并发症的风险。越来越多的实验证据支持这样一种观点,即糖尿病并发症的风险可能与氧化应激、蛋白质的非酶糖基化、表观遗传变化和慢性炎症有关,这为“代谢记忆”理论奠定了基础。从临床角度来看,该理论支持尽早进行积极治疗,目标是尽快使代谢控制正常化。除了更好地控制糖尿病患者的血糖水平外,引入能够减少活性物质和糖基化的治疗药物可能也被证明是有益的,以便将糖尿病长期并发症降至最低。在本综述中,我们根据这一理论评估葡萄糖摄入和代谢的影响。

相似文献

1
The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.“代谢记忆”理论与高血糖的早期治疗对预防糖尿病并发症的作用
Nutrients. 2017 Apr 28;9(5):437. doi: 10.3390/nu9050437.
2
The role of "metabolic memory" in the natural history of diabetes mellitus.“代谢记忆”在糖尿病自然病程中的作用。
Pol Arch Med Wewn. 2009 Jul-Aug;119(7-8):493-500.
3
Hypothesis: the "metabolic memory", the new challenge of diabetes.假说:“代谢记忆”,糖尿病的新挑战。
Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S2-6. doi: 10.1016/S0168-8227(09)70002-6.
4
Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?临床综述2:“代谢记忆”:预防糖尿病并发症是否仅严格控制血糖就足够?
J Clin Endocrinol Metab. 2009 Feb;94(2):410-5. doi: 10.1210/jc.2008-1824. Epub 2008 Dec 9.
5
The emerging challenge in diabetes: the "metabolic memory".糖尿病领域的新挑战:“代谢记忆”。
Vascul Pharmacol. 2012 Nov-Dec;57(5-6):133-8. doi: 10.1016/j.vph.2012.05.005. Epub 2012 May 16.
6
Hypothesis: the 'metabolic memory', the new challenge of diabetes.假说:“代谢记忆”,糖尿病的新挑战。
Diabet Med. 2007 Jun;24(6):582-6. doi: 10.1111/j.1464-5491.2007.02138.x. Epub 2007 May 8.
7
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.AGEs,而不是高血糖,是糖尿病微血管并发症的罪魁祸首:一种“糖基化中心”的观点。
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9. doi: 10.1016/j.numecd.2013.04.004. Epub 2013 Jun 17.
8
[Intensive blood glucose reduction: yes or no?].[强化血糖降低:是与否?]
MMW Fortschr Med. 2015 Mar 5;157(4):18-9. doi: 10.1007/s15006-015-2752-8.
9
Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.高血糖症:糖尿病并发症发病机制中非酶糖基化与氧化应激之间的桥梁。
Diabetes Nutr Metab. 1999 Feb;12(1):42-6.
10
Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?糖尿病的管理:同时针对高血糖和氧化应激是否会是更好的万灵药?
Int J Mol Sci. 2012;13(3):2965-2972. doi: 10.3390/ijms13032965. Epub 2012 Mar 6.

引用本文的文献

1
"Circulating MiRNAs targeting antioxidant genes: potential biomarkers for type 2 diabetes mellitus".靶向抗氧化基因的循环微小RNA:2型糖尿病的潜在生物标志物
Mol Biol Rep. 2025 Jun 28;52(1):648. doi: 10.1007/s11033-025-10768-w.
2
The partial clinical remission phase of type 1 diabetes: early-onset dyslipidemia, long-term complications, and disease-modifying therapies.1型糖尿病的部分临床缓解期:早发性血脂异常、长期并发症及疾病改善疗法。
Front Endocrinol (Lausanne). 2025 Apr 16;16:1462249. doi: 10.3389/fendo.2025.1462249. eCollection 2025.
3
GLU24/7 study: cardiometabolic health risk factors in night shift workers - protocol for a 2-year longitudinal study in an industrial setting in Norway.

本文引用的文献

1
Proteomics reveals the effects of sustained weight loss on the human plasma proteome.蛋白质组学揭示了持续体重减轻对人体血浆蛋白质组的影响。
Mol Syst Biol. 2016 Dec 22;12(12):901. doi: 10.15252/msb.20167357.
2
Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study.胰高血糖素样肽-1受体激动剂与糖尿病心血管疾病:LEADER研究的启示
Metab Syndr Relat Disord. 2016 Oct;14(8):375-377. doi: 10.1089/met.2016.29008.swi. Epub 2016 Aug 23.
3
Epigenetic changes in diabetes.糖尿病中的表观遗传变化。
GLU24/7研究:夜班工作者的心血管代谢健康风险因素——挪威工业环境中一项为期两年的纵向研究方案
BMJ Open. 2025 Apr 29;15(4):e098896. doi: 10.1136/bmjopen-2025-098896.
4
Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments.糖尿病及相关血管疾病:发病机制、并发症与不断发展的治疗方法
Adv Ther. 2025 Jun;42(6):2659-2678. doi: 10.1007/s12325-025-03185-9. Epub 2025 Apr 19.
5
A Narrative Review: Relationship Between Glycemic Variability and Emerging Complications of Diabetes Mellitus.一篇叙述性综述:血糖变异性与糖尿病新出现并发症之间的关系
Biomolecules. 2025 Jan 28;15(2):188. doi: 10.3390/biom15020188.
6
The efficacy and safety of qiwei baizhu san in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.七味白术散治疗2型糖尿病的疗效与安全性:一项系统评价与Meta分析
Front Pharmacol. 2025 Jan 7;15:1501990. doi: 10.3389/fphar.2024.1501990. eCollection 2024.
7
A mathematical model of glomerular fibrosis in diabetic kidney disease to predict therapeutic efficacy.一种用于预测糖尿病肾病中肾小球纤维化治疗效果的数学模型。
Front Pharmacol. 2024 Oct 25;15:1481768. doi: 10.3389/fphar.2024.1481768. eCollection 2024.
8
Effectiveness of therapeutic patient education on diabetes in prison.监狱中治疗性患者教育对糖尿病的效果。
Rev Esp Sanid Penit. 2024 May-Aug;26(2):57-64. doi: 10.18176/resp.00088.
9
Bixin Combined with Metformin Ameliorates Insulin Resistance and Antioxidant Defenses in Obese Mice.胭脂树橙联合二甲双胍改善肥胖小鼠的胰岛素抵抗和抗氧化防御能力。
Pharmaceuticals (Basel). 2024 Sep 12;17(9):1202. doi: 10.3390/ph17091202.
10
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation].[高选择性钠-葡萄糖协同转运蛋白2抑制剂恩格列净作为慢性脑循环障碍情况下脑保护手段的研究]
Probl Endokrinol (Mosk). 2024 Sep 15;70(4):44-56. doi: 10.14341/probl13336.
Neurosci Lett. 2016 Jun 20;625:64-9. doi: 10.1016/j.neulet.2016.04.046. Epub 2016 Apr 27.
4
Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.依帕司他通过减轻氧化应激和抑制多元醇通路来预防糖尿病周围神经病变。
Neural Regen Res. 2016 Feb;11(2):345-51. doi: 10.4103/1673-5374.177745.
5
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.蛋白负荷可增强维格列汀在 2 型糖尿病患者中的降糖疗效。
Diabetes Care. 2016 Apr;39(4):511-7. doi: 10.2337/dc15-2298. Epub 2016 Jan 19.
6
Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.2型糖尿病患者的进餐顺序与血糖波动、胃排空及肠促胰岛素分泌:一项随机、对照交叉探索性试验
Diabetologia. 2016 Mar;59(3):453-61. doi: 10.1007/s00125-015-3841-z. Epub 2015 Dec 24.
7
The miRNA Interactome in Metabolic Homeostasis.代谢稳态中的微小RNA相互作用组
Trends Endocrinol Metab. 2015 Dec;26(12):733-745. doi: 10.1016/j.tem.2015.09.006. Epub 2015 Oct 20.
8
50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.展望未来五十年:高血糖导致糖尿病并发症的机制。
Diabetologia. 2015 Aug;58(8):1708-14. doi: 10.1007/s00125-015-3600-1. Epub 2015 Apr 24.
9
Noncoding RNAs in diabetes vascular complications.糖尿病血管并发症中的非编码RNA
J Mol Cell Cardiol. 2015 Dec;89(Pt A):42-50. doi: 10.1016/j.yjmcc.2014.12.014. Epub 2014 Dec 20.
10
Antisense oligonucleotides, microRNAs, and antibodies.反义寡核苷酸、微小核糖核酸和抗体。
Handb Exp Pharmacol. 2015;224:649-89. doi: 10.1007/978-3-319-09665-0_22.